#ovarian cancer

FDA Approves New Treatment Option for Ovarian Cancer

A campaign in the name of Casey McIntyre, who died of ovarian cancer, has raised $576,000 to eliminate others’ medical debt.

New therapies tested delayed relapse and, in some cases, lengthened survival, for women with cervical, ovarian and endometrial cancers.

Tennis star Pete Sampras revealed his wife’s journey with ovarian cancer and asked for the public’s thoughts and prayers.

How Amy Bibbey found “small gifts” while navigating surgery, chemotherapy, and clinical trials for recurrent stage 3 ovarian cancer.

AssessYourRisk, developed by Dana-Farber Cancer Institute, uses a simple quiz to assess a users’ risk of breast or ovarian cancer.

Most patients who used “magic mushrooms” along with psychotherapy experienced a sustained reduction in depression symptoms.

Tumor-treating fields therapy uses electricity delivered via a wearable device to kill cancer cells.

Team uses large-scale proteogenomic changes to identify which ovarian cancer patients should look beyond standard treatment options.

CU Cancer Center member Saketh Guntupalli, MD, was asked to write an expert review for the British Medical Journal.

African American women’s use of chemical hair relaxers might help explain their higher risk of death from hormone-related cancers.

Germline testing, especially for certain breast, ovarian, pancreatic and prostate cancers, can guide treatment choices.

Response rates ranged from 56% to 85% for several types of tumors with high HER2 expression.

While expensive new drugs are developed, thousands of people can’t get a drug like cisplatin that costs as little as $6 a dose.

New approach could provide insights into cancer progression and treatment response, leading to more precise therapies.

Screening should be done based on which organs a person has, not their gender identity.

A nationwide shortage of cancer drugs is causing thousands of patients to experience delays in treatment.